HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yen, R.-F. Articles by Chen, T. H.-H. Search for Related Content PubMed PubMed Citation Articles by Yen, R.-F. Articles by Chen, T. H.-H.

Whole-Body ¹⁸F-FDG PET in Recurrent or Metastatic Nasopharyngeal Carcinoma

¹ Department of Nuclear Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
² Institute of Preventive Medicine, National Taiwan University College of Public Health, Taipei, Taiwan
³ Department of Oncology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan

View larger version (70K): [in a new window]   FIGURE 1. 18F-FDG PET images of 51-y-old male patient who underwent PET examination 8 mo after CCRT (pretherapy stage IVA) show a biopsy-proven cervical lymph node metastasis at left submandibular region (arrows) and intense 18F-FDG uptake in right cervical muscle (arrowhead). No lymph node metastasis in the right neck was observed during clinical follow-up in this patient.

View larger version (58K): [in a new window]   FIGURE 2. Image of 63-y-old male patient who underwent 18F-FDG PET examination 8 mo after completion of CCRT reveals multiple 18F-FDG hypermetabolic lesions in right neck, mediastinum, and bilateral lungs. Patient died 13 mo after PET study.

View larger version (20K): [in a new window]   FIGURE 3. Survival for PET-positive and PET-negative patient groups (A) and stage I, II and stage III, IV patient groups (B).